SCHEMBL5509002

SCHEMBL5509002

Cc1cc2nc(C(Cl)(Cl)Cl)[nH]c2cc1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP6 P51161 1/20 0.53
MAPT P10636 3/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
ATM Q13315 2/20 0.52
KDM4E B2RXH2 2/20 0.52
CACNA1B Q00975 1/20 0.52
APBA1 Q02410 1/20 0.52
MCL1 Q07820 1/20 0.52
PSMD14 O00487 1/20 0.49
MMP2 P08253 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
POLB P06746 1/20 0.46
HPGD P15428 1/20 0.46
AMY1A P0DUB6 5/20 0.42
METAP1 P53582 2/20 0.41
METAP2 P50579 1/20 0.41
CBFB Q13951 1/20 0.41
HRH4 Q9H3N8 1/20 0.41
AR P10275 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4352219 0.87 AR (0.47) FABP6MAPTMEN1KMT2AATM
SCHEMBL10248126 0.82 FABP6 (0.55) FABP6MAPTMEN1KMT2AATM
SCHEMBL7807160 0.81 MAPT (0.69) FABP6MAPTMEN1KMT2AATM
SCHEMBL11647722 0.79 FABP6 (0.52) FABP6MAPTMEN1KMT2AATM
SCHEMBL5540352 0.78 AR (0.55) MAPTMEN1KMT2AKDM4EPOLB
SCHEMBL4349193 0.78 KMT2A (0.41) MAPTMEN1KMT2AKDM4EPOLB
SCHEMBL1422562 0.77 KDM4E (0.45) MAPTMEN1KMT2AKDM4EPOLB
SCHEMBL14390024 0.77 MAPT (0.49) FABP6MAPTMEN1KMT2AATM
SCHEMBL1192746 0.74 FABP6 (0.59) FABP6MAPTMEN1KMT2AATM
SCHEMBL5510808 0.73 AR (0.47) MAPTMEN1KMT2AKDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1846409-A1 OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES Pfizer Limited (GB) 2007-10-24 EP disclosed
EP-1671972-A1 Octahydropyrrolo[3,4-c]pyrrole derivatives Pfizer Limited (GB) 2006-06-21 EP disclosed
WO-2006056848-A1 OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES PFIZER LIMITED (GB) 2006-06-01 WO disclosed
US-20060111416-A1 Octahydropyrrolo[3,4-C]pyrrole derivatives PFIZER INC. 2006-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111416-A1 Octahydropyrrolo[3,4-C]pyrrole derivatives DPYD, PAH, DHPS FABP6 1902/4885MAPT 1856/4885MEN1 2745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.